Evidence map›Paper›PMID 39962730›Full record

ArticleRenal failure2025

Exploring the association of natriuretic peptides with QTc interval in hemodialysis patients.

Yoshihiro Matsumoto, Yasuo Mori, Shinji Kageyama, Kazuaki Yoshimura, Takao Saito, Risako Terada, Yohichi Nojima

Abstract read
In one paragraph

Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yoshihiro MatsumotoNephrology and Dialysis, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Yasuo MoriHemodialysis, Shibukawa Clinic, Shizuoka, Japan.
Shinji KageyamaUrology, Kageyama Clinic, Shizuoka, Japan.
Kazuaki YoshimuraHemodialysis, Shibukawa Clinic, Shizuoka, Japan.
Takao SaitoHemodialysis, Higashi-Shizuoka Jin Clinic, Shizuoka, Japan.
Risako TeradaNephrology and Dialysis, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Yohichi NojimaNephrology and Dialysis, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn patients undergoing hemodialysis (HD), cardiovascular (CV) disease, particularly sudden cardiac death (SCD), is a major cause of mortality. Independent predictors of SCD include a prolonged QT interval on electrocardiography (ECG) and elevated levels of natriuretic peptides (NPs). This study explores the association between the QTc interval and NPs in HD patients.

methodsThis cross-sectional study involved 207 HD patients, having a heart rate of 57 to 103 bpm, displaying sinus rhythm and no extrasystoles in ECG reports. Before the 2nd HD of the week, we conducted ECG and blood tests for atrial NP (ANP), brain NP (BNP), and N-terminal proBNP (NT-proBNP). The heart rate-corrected QT (QTc) was calculated using Bazett formula. Our analysis focused on the association between QTc and each NP, along with evaluating clinically relevant variables related to the QTc interval.

resultsUnivariate analyses indicated robust correlations among the NPs, with each NP significantly associated with the QTc interval. Multiple regression analyses of the three NPs revealed that NT-proBNP demonstrated the strongest predictive ability for the QTc interval. Independent predictors of prolonged QTc included lower corrected calcium (cCa) levels (

conclusionIn HD patients, NT-proBNP shows a stronger link with the QTc interval than BNP or ANP. Integrating clinical management considering both QTc and log NT-proBNP levels might help reduce CV events. Additionally, vigilance regarding low K or cCa levels is recommended from the perspective of the QTc interval.

Indexed as

Atrial Natriuretic FactorDeath, Sudden, CardiacKidney Failure, ChronicLong QT SyndromeNatriuretic Peptide, BrainPeptide FragmentsRenal DialysisAdultAgedCross-Sectional StudiesElectrocardiographyFemaleHeart RateHumansMaleMiddle AgedAtrial Natriuretic FactorNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Cardiovascular diseasehemodialysisN-terminal proBNPQTc intervalsudden cardiac death

Identifiers

PMID39962730
PMCPMC11837943

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.